Literature DB >> 1430059

Persistence of specific IgM and low avidity specific IgG1 following primary rubella.

H I Thomas1, P Morgan-Capner, G Enders, S O'Shea, D Caldicott, J M Best.   

Abstract

Persistence of specific IgM in sera following primary rubella infection was compared with the maturation of the specific IgG1 response. 206 sera, from 171 patients with primary rubella, taken 1 day to 2.5 years after onset of illness, were tested. Rubella-specific IgM was detected by M-antibody capture radioimmunoassay in 100% of sera taken 15-28 days after onset, but in only 9% taken 3-4 months after onset. However, using the diethylamine (DEA) shift value (DSV) method, low avidity specific IgG1 was detected in 91% sera taken at 3-4 months and at 5-7 months 21% of sera remained positive. Using an avidity index method, with urea in the wash buffer, none of the sera were positive for low avidity specific IgG1 beyond 3 months after onset. With DEA in the wash buffer, the number of sera positive rose to 38% at 3-4 months. Thus, the DSV method for detecting low avidity specific IgG1 is a useful additional test for confirming or refuting a diagnosis of primary rubella and is of particular value for assessing pregnant patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1430059     DOI: 10.1016/0166-0934(92)90133-x

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  15 in total

1.  Reliability of low-avidity IgG and of IgA in the diagnosis of primary infection by rubella virus with adaptation of a commercial test.

Authors:  J Gutiérrez; M J Rodríguez; F De Ory; G Piédrola; M C Maroto
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

2.  Evaluation of three immunoassays used for detection of anti-rubella virus immunoglobulin M antibodies.

Authors:  Wayne Dimech; Lena Panagiotopoulos; Joan Marler; Nicolas Laven; Susan Leeson; Elizabeth M Dax
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

3.  Evaluation of commercial rubella immunoglobulin G avidity assays.

Authors:  Samira Mubareka; Hannah Richards; Michael Gray; Graham A Tipples
Journal:  J Clin Microbiol       Date:  2006-11-08       Impact factor: 5.948

4.  Humoral immune response after primary rubella virus infection and after vaccination.

Authors:  C Vauloup-Fellous; L Grangeot-Keros
Journal:  Clin Vaccine Immunol       Date:  2007-03-07

5.  Prenatal diagnosis of rubella virus infection by direct detection and semiquantitation of viral RNA in clinical samples by reverse transcription-PCR.

Authors:  M G Revello; F Baldanti; A Sarasini; M Zavattoni; M Torsellini; G Gerna
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

6.  Evaluation of rubella virus immunoglobulin G (IgG) and IgM assays with the new Vidia instrument.

Authors:  Maria Cristina Medici; Monica Martinelli; Valeria Albonetti; Carlo Chezzi; Giuseppe Dettori
Journal:  J Clin Microbiol       Date:  2008-03-26       Impact factor: 5.948

7.  Reliability of four methods for the diagnosis of acute infection by Epstein-Barr virus.

Authors:  J Gutiérrez; M Rodríguez; C Maroto; G Piédrola
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

8.  Comparison of four enzyme immunoassays for detection of immunoglobulin M antibodies against rubella virus.

Authors:  L Matter; M Gorgievski-Hrisoho; D Germann
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

9.  The diagnosis of toxoplasmosis using IgG avidity.

Authors:  R E Holliman; R Raymond; N Renton; J D Johnson
Journal:  Epidemiol Infect       Date:  1994-04       Impact factor: 2.451

10.  Application of low-avidity immunoglobulin G studies to diagnosis of Epstein-Barr virus infectious mononucleosis.

Authors:  F de Ory; J Antonaya; M V Fernández; J M Echevarría
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.